Dare Bioscience Inc. (NASDAQ:DARE) went down by -1.79% from its latest closing price compared to the recent 1-year high of $3.85. The company’s stock price has collected -4.62% of loss in the last five trading sessions. Press Release reported on 09/08/21 that Daré Bioscience to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Is It Worth Investing in Dare Bioscience Inc. (NASDAQ :DARE) Right Now?
Plus, the 36-month beta value for DARE is at 1.70. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Dare Bioscience Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $5.50. DARE currently public float of 47.69M and currently shorts hold a 9.73% ratio of that float. Today, the average trading volume of DARE was 9.61M shares.
DARE’s Market Performance
DARE stocks went down by -4.62% for the week, with a monthly jump of 3.12% and a quarterly performance of 23.13%, while its annual performance rate touched 57.14%. The volatility ratio for the week stands at 5.25% while the volatility levels for the past 30 days are set at 5.64% for Dare Bioscience Inc.. The simple moving average for the period of the last 20 days is -0.69% for DARE stocks with a simple moving average of 0.08% for the last 200 days.
DARE Trading at 1.61% from the 50-Day Moving Average
After a stumble in the market that brought DARE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.14% of loss for the given period.
Volatility was left at 5.64%, however, over the last 30 days, the volatility rate increased by 5.25%, as shares surge +8.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.43% upper at present.
During the last 5 trading sessions, DARE fell by -4.62%, which changed the moving average for the period of 200-days by +24.06% in comparison to the 20-day moving average, which settled at $1.6680. In addition, Dare Bioscience Inc. saw 23.13% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for DARE
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.91.